PMID:
Physiol Meas. 2018 11 28 ;39(11):115008. Epub 2018 Nov 28. PMID: 30485255
Abstract Title:
Self-identified gadolinium toxicity: comparison of gadolinium in bone and urine to healthy gadolinium-based contrast agent exposed volunteers.
Abstract:
OBJECTIVE: To report additional gadolinium bone and urine data that can contribute to gaps in knowledge with respect to gadolinium uptake and retention in the body.APPROACH: In vivo measurements of gadolinium retention in the tibia bone were performed on individuals self-identified as exhibiting symptoms of gadolinium toxicity as a result of receiving GBCA, as well as on control individuals. Gadolinium urine measurements for controls, symptomatic exposed, and non-symptomatic exposed were conducted through Mayo Medical Laboratories.MAIN RESULTS: Gadolinium bone concentration in the exposed group is significantly higher than the control group (p
Health Time 